Featured Research

from universities, journals, and other organizations

Protein discovered that alters nutrition of breast cancer cells

Date:
April 5, 2011
Source:
Elhuyar Fundazioa
Summary:
New research finds that the lack or loss of a protein in the cells known as SIRT3 induces the proliferation of breast cancer, suggesting that this protein may be a therapeutic target in the development of effective therapies for cancer.

New research published in the journal Cancer Cell reveals that the lack or loss of a protein in the cells known as SIRT3, induces the proliferation of this disease, suggesting that this protein may be a therapeutic target in the development of effective therapies for cancer.

Related Articles


The research was led by Dr. Marcia Haigis of Harvard Medical School, with the participation of Dr. Arkaitz Carracedo, from the Proteomics Laboratory at CIC bioGUNE.

One of the grand aims of the scientific community is to identify the characteristics that differentiate normal cells from cancerous ones in order to subsequently develop therapies that wipe out the aberrant cells without affecting the normal ones. One hundred years ago, a researcher named Otto Warburg observed that cancerous cells feed in a singular manner: instead of using nutrients to produce energy, it seems they waste part of the food through a less efficient metabolism. Warburg maintained the hypothesis that cancer cells have an aberrant metabolism, which he attributed to a technical defect in these cells. They did not use food to generate energy (ATP) but to generate biomass and build more cells, divide, proliferate, etc.

"In recent years, we have come to understand this phenomenon better. Paradoxically, the cancer cells obtain sufficient energy from nutrients -- equivalent to the electricity for supplying all the appliances in our house -- while what is limiting for them is material to build more cells or what we can imagine as the bricks to build more houses," explained Dr. Carracedo. "To this end, they modify their metabolism in order to create more of these building blocks (cell membrane, ADN, proteins, and so on). This change in the metabolic behaviour of the tumour cell is known as the Warburg Effect, in honour of the researcher."

With this precedent, it is clear that if the way the metabolism of tumour cells is reprogrammed can be understood, more powerful and specific therapies can be designed. Dr. Haigis's team focused their research on new proteins that regulate the metabolism of the cells and known as Sirtuins, and detected that if a protein of this family of sirtuins (known as SIRT3) were eliminated from the cells, these modified their mode of feeding on and processing of nutrients, showing a remarkable similarity with a cancerous cell.

"We discovered that a loss of SIRT3 triggered the Warburg Effect. SIRT3 acts as a 'guardian' in the cell, ensuring that the metabolic processes function correctly. Nevertheless, with loss of SIRT3, another very important protein for the cell, known as HIF1α and which has to be strictly controlled, goes out of control and alters the metabolism," stated Dr. Carracedo.

According to this hypothesis, a cancerous cell will benefit from the elimination of SIRT3 protein. "We confirmed this idea after observing that cells in mice without SIRT3 generated cancers that developed more," stated Br Carracedo. "These genes are fighting constantly. When we lose the SIRT3 gene, the HIF1α protein increases, it destabilises. This promotes tumour growth."

In order to undertake the most important confirmation -- the extrapolation of data to human beings -- pathology and bioinformatics experts were included in this project. The researchers helped demonstrate that, effectively, many cancers, and principally breast cancer, presented reduced levels of SIRT3, together with signs of altered metabolism. Thus, they arrived at the conclusion that SIRT3 protein is a 'guardian' of the metabolism, and that the design of pharmaceutical drugs for promoting this activation could be of great interest in the treatment of cancer.


Story Source:

The above story is based on materials provided by Elhuyar Fundazioa. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lydia W.S. Finley, Arkaitz Carracedo, Jaewon Lee, Amanda Souza, Ainara Egia, Jiangwen Zhang, Julie Teruya-Feldstein, Paula I. Moreira, Sandra M. Cardoso, Clary B. Clish, Pier Paolo Pandolfi, Marcia C. Haigis. SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization. Cancer Cell, 2011; 19 (3): 416 DOI: 10.1016/j.ccr.2011.02.014

Cite This Page:

Elhuyar Fundazioa. "Protein discovered that alters nutrition of breast cancer cells." ScienceDaily. ScienceDaily, 5 April 2011. <www.sciencedaily.com/releases/2011/04/110405093556.htm>.
Elhuyar Fundazioa. (2011, April 5). Protein discovered that alters nutrition of breast cancer cells. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2011/04/110405093556.htm
Elhuyar Fundazioa. "Protein discovered that alters nutrition of breast cancer cells." ScienceDaily. www.sciencedaily.com/releases/2011/04/110405093556.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins